Fiala

Peptide library › Growth hormone axis

Somapacitan

Also known as Sogroya

FDA-approved drugGrowth hormone axis

Once-weekly growth hormone treatment for children and adults with growth hormone deficiency.

What people use it for

What Somapacitan does in the body

Growth hormone with a small change that lets it bind to albumin in the blood, so it lasts long enough for one injection a week instead of daily.

Strength of evidence

Strong: Phase 3 trials showed similar results to daily growth hormone.

Look up the evidence

Live searches of official databases. New to the terms? See the glossary.

Reported side effects & risks

Who should avoid it or take extra care

Not a complete list. Check with a doctor or pharmacist about your own health and medicines.

Regulatory status

FDA-approved in 2020 for adults, with children's growth hormone deficiency added in 2023 and further children's short-stature uses later. Prescription only.

How it's taken

Route: Injection under the skin, once weekly

How long it lasts (half-life): About 2 to 3 days

Storage

Refrigerated before first use; follow the pen instructions afterwards.

Keep track of Somapacitan privately

Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.

Open Somapacitan in Fiala How to install
Not medical advice. This page is general education. Talk to a qualified clinician before starting, stopping or changing any treatment.

More in Growth hormone axis